Table 3. Univariate and multivariate Cox regression analyses of the prognostic variables in ESCC patients.
Variables | Subset | Hazard ratio | 95% CI | P |
Univariate analysis(n = 168) | ||||
Age | <60 vs. ≥60 | 1.390 | (0.924–2.091) | 0.114 |
Gender | Male vs. Female | 0.472 | (0.284–0.784) | 0.004 |
T-stage | T1+T2 vs. T3+T4 | 2.326 | (1.479–3.650) | 0.000 |
N-stage | No vs. Yes | 2.254 | (1.533–3.313) | 0.000 |
Histological grade | G1 vs. G2–G3 | 0.863 | (0.652–1.142) | 0.520 |
Clinical stage | I–II vs III–IV | 2.741 | (1.841–4.081) | 0.000 |
14-3-3σ | Low vs. High | 0.508 | (0.316–0.816) | 0.005 |
Multivariate analysis | ||||
Age | <60 vs. ≥60 | 1.199 | (0.750–1.917) | 0.449 |
Gender | Male vs. Female | 0.658 | (0.348–1.241) | 0.196 |
T-stage | T1+T2 vs. T3+T4 | 2.577 | (1.605–4.150) | 0.000 |
N-stage | No vs. Yes | 0.755 | (0.167–3.418) | 0.715 |
Histological grade | G1 vs. G2–G3 | 0.621 | (0.323–1.195) | 0.154 |
Clinical stage | I–II vs. III–IV | 3.042 | (0.679–13.635) | 0.146 |
14-3-3σ | Low vs. High | 0.466 | (0.251–0.866) | 0.016 |